Lilly's Zypadhera has been recommended in Europe for use in stabilising schizophrenic patients who are already receiving treatment. The European …
Boehringer Ingelheim and Pfizer have released new data on Spiriva to defend the safety record of the chronic obstructive pulmonary …
Pharmaceutical companies operating in the UK are experiencing reduced competition from European parallel importers, thanks to the weakness of the …
Europe’s biotech sector is being hit hard by the credit crunch, with small and medium-sized companies being starved of funding …
Is cost containment impacting pharmaceutical innovation?With the cost of healthcare provision spiraling, governments and payers across the seven major markets …
UK regulators and the pharma industry have come together to launch a new website for patients. The 'mymedicine' site is …
NICE has recommended Boehringer Ingelheim's novel anti-clotting pill Pradaxa, giving it a marketing edge over Bayer's rival treatment Xarelto. Pradaxa …
Lilly is to be the first pharmaceutical company to disclose payments made to US doctors for consultancy services and key …
Merck Serono's Kuvan is on track to become the first medicine approved in Europe for two rare neurological disorders. Regulatory …
How did you find your way into this role?
Rival vaccine products that will prevent thousands of women developing cervical cancer have been declared joint winners of the prestigious …
Patients suffering from cancer won't have to pay for prescriptions after April next year under new government plans. Prime minister …
Sanofi-Aventis' acquisition of Czech generics firm Zentiva is back on, after the pharma company increased its offer by nearly 10%. …
The April publication of the long-awaited pharmacy White Paper – 'Building on Strengths, Delivering the Future' – spells exciting times …
Monoclonal antibody sales to almost double by 2013In 2007, total global monoclonal antibody sales reached $26 billion and are forecast …
Indian generics firm Ranbaxy has hired former New York mayor Rudolf Giuliani to help reverse an FDA block on imports …
AstraZeneca has launched a once-daily version of Seroquel in the UK. The drug is used to treat schizophrenia and manic …
The King's Fund says the current ban on NHS patients paying privately for 'top-up' drugs is not working. The Department …
How did you find your way into your current role?I came into things via the ‘traditional’ route. After my biochemistry …